IN2013MN02451A - - Google Patents

Download PDF

Info

Publication number
IN2013MN02451A
IN2013MN02451A IN2451MUN2013A IN2013MN02451A IN 2013MN02451 A IN2013MN02451 A IN 2013MN02451A IN 2451MUN2013 A IN2451MUN2013 A IN 2451MUN2013A IN 2013MN02451 A IN2013MN02451 A IN 2013MN02451A
Authority
IN
India
Prior art keywords
tissue
standard
molecule
relates
range
Prior art date
Application number
Inventor
Jonathan Stauber
David Bonnel
Original Assignee
Imabiotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imabiotech filed Critical Imabiotech
Publication of IN2013MN02451A publication Critical patent/IN2013MN02451A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/38Diluting, dispersing or mixing samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/4833Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/286Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
    • G01N2001/2866Grinding or homogeneising
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N2001/2893Preparing calibration standards

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

The invention relates to a method for preparing a range of dilutions of at least one standard molecule for a tissue according to which use is made of a ground tissue to which the standard molecule is added the whole being conditioned and fractionated before the analysis of a fraction of said tissue. The invention also relates to a method for detecting and quantifying at least one target molecule in at least one tissue using a standard range according to the invention.
IN2451MUN2013 2011-05-31 2012-05-29 IN2013MN02451A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1154731A FR2976076B1 (en) 2011-05-31 2011-05-31 METHOD FOR DETECTING AND QUANTIFYING TARGET MOLECULE IN TISSUE
PCT/FR2012/051205 WO2012164221A1 (en) 2011-05-31 2012-05-29 Method for detecting and quantifying a target molecule in a tissue

Publications (1)

Publication Number Publication Date
IN2013MN02451A true IN2013MN02451A (en) 2015-04-17

Family

ID=46420402

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2451MUN2013 IN2013MN02451A (en) 2011-05-31 2012-05-29

Country Status (12)

Country Link
US (1) US10132796B2 (en)
EP (1) EP2715310B1 (en)
JP (1) JP6170911B2 (en)
KR (1) KR102004350B1 (en)
CN (1) CN103688151B (en)
AU (1) AU2012264458B2 (en)
CA (1) CA2837153C (en)
DK (1) DK2715310T3 (en)
ES (1) ES2922478T3 (en)
FR (1) FR2976076B1 (en)
IN (1) IN2013MN02451A (en)
WO (1) WO2012164221A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014128309A1 (en) * 2013-02-25 2014-08-28 Imabiotech Method to evaluate the tissue targeting of a molecule of interest
CN103336128A (en) * 2013-06-08 2013-10-02 天津药物研究院 Detection method of tissue distribution of small molecule polypeptide drugs
JP7094880B2 (en) * 2015-11-06 2022-07-04 ヴェンタナ メディカル システムズ, インク. Representative diagnostic method
KR101996666B1 (en) * 2016-05-02 2019-07-04 주식회사 엘지화학 Method for quantitative analysis
JP7010373B2 (en) 2018-05-30 2022-01-26 株式会社島津製作所 Spectral data processing equipment and analysis equipment
WO2021168578A1 (en) * 2020-02-27 2021-09-02 Lsk Technologies Inc. Systems and methods for characterization of an assay from regions of interest using optical reactions
WO2021175842A1 (en) 2020-03-02 2021-09-10 Universiteit Maastricht Quality control standards for mass spectrometry imaging

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036972A2 (en) * 1999-11-16 2001-05-25 Genentech, Inc. Elisa for vegf
EP1550862B1 (en) * 2002-10-04 2012-01-25 Protosera Inc. Method of identifying an analyte by gel electrophoresis-mass spectrometry
US20040096907A1 (en) * 2002-11-06 2004-05-20 Bernd Bohrmann Quantification of beta amyloid
JP2005181011A (en) * 2003-12-17 2005-07-07 Yoshio Yamauchi Method of analyzing protein
JP4547173B2 (en) 2004-03-17 2010-09-22 シスメックス株式会社 Diabetes care support system
EP1889047B1 (en) 2005-06-07 2011-08-10 Centre National De La Recherche Scientifique -Cnrs- Use of conjugates with linkers cleavable by photodissociation or fragmentation for mass spectrometry analysis of tissue sections
EP2163900A1 (en) 2008-09-04 2010-03-17 Commissariat A L'energie Atomique New method of imaging by mass spectrometry and new mass tag associated trityl derivatives
WO2010041459A1 (en) * 2008-10-08 2010-04-15 積水メディカル株式会社 Method for quantitative analysis of drug metabolite and analyzer
WO2011073740A1 (en) 2009-12-15 2011-06-23 Centre National De La Recherche Scientifique (Cnrs) Matrices for mass spectrometry imaging
FR2973112B1 (en) 2011-03-21 2018-05-25 Imabiotech METHOD FOR DETECTING AND QUANTIFYING TARGET MOLECULE IN A SAMPLE
EP2767832A1 (en) 2013-02-18 2014-08-20 Imabiotech Photo or chemolabile conjugates for molecules detection
WO2014128309A1 (en) 2013-02-25 2014-08-28 Imabiotech Method to evaluate the tissue targeting of a molecule of interest

Also Published As

Publication number Publication date
EP2715310B1 (en) 2022-04-27
JP6170911B2 (en) 2017-07-26
KR20140051187A (en) 2014-04-30
US10132796B2 (en) 2018-11-20
AU2012264458A1 (en) 2014-01-09
EP2715310A1 (en) 2014-04-09
CA2837153A1 (en) 2012-12-06
ES2922478T3 (en) 2022-09-15
WO2012164221A1 (en) 2012-12-06
CN103688151B (en) 2016-05-18
AU2012264458B2 (en) 2015-09-24
US20140106391A1 (en) 2014-04-17
FR2976076A1 (en) 2012-12-07
FR2976076B1 (en) 2015-02-27
DK2715310T3 (en) 2022-07-25
KR102004350B1 (en) 2019-07-26
CA2837153C (en) 2019-06-25
JP2014520259A (en) 2014-08-21
CN103688151A (en) 2014-03-26

Similar Documents

Publication Publication Date Title
IN2013MN02451A (en)
CY1120390T1 (en) COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES RELATING TO NURSES
EP3057620A4 (en) Methods of using spect/ct analysis for staging cancer
AR089993A1 (en) PEPTIDOMIMETIC MACROCICLES
HK1201180A1 (en) Method and system for analyzing biological specimens by spectral imaging
EP2715772A4 (en) Direct sample analysis ion source
CO6930363A2 (en) Benzylindazoles substituted for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
BR112013004012A2 (en) antibodies to epidermal growth factor receptor 3 (her3).
ZA201407051B (en) Compositions and methods for the collection and isolation of nucleic acids from biological specimens
CO7121321A2 (en) A method and system for multi-energy computerized tomographic analysis of drilling clippings
IN2014DN04645A (en)
WO2013033609A3 (en) Methods and compositions for the treatment and diagnosis of cancer
BR112013032816A2 (en) method for the analysis of biological specimens by spectral imaging
SG10201602113TA (en) Systems And Methods For Biological Analysis
CR20140169A (en) PROTEINS OF UNION TO THE ANTIGEN CD27L
BR112013013756A2 (en) multiaxial pedicular fixation set and method of use
SG11201601031QA (en) Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method
EP2926658A4 (en) Kit for producing transparentized biological specimen, and method for producing transparentized biological specimen
BR112013022552A2 (en) alkyne substituted quinazoline compounds and methods of use
IL241496A0 (en) Method and system for analyzing biological specimens by spectral imaging
IL236132A0 (en) Euglobulin-based method for determining the biological activity of defibrotide
GB201300869D0 (en) Improvements in or relating to sample analysis
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
FR2997085B1 (en) PROCESS FOR PREPARING RETICULATED GEL
EP2732068B8 (en) Method for improving the wear resistance of dyed surgical instruments